Colorectal Cancer Clinical Trials in Ventura, CA

Colorectal Cancer Clinical Trials in Ventura, CA

View the best 10 colorectal cancer medical studies in Ventura, California. Access promising new therapies by applying to a Ventura-based Colorectal Cancer clinical trial.

Trials in Ventura, California

Here are the top 10 medical studies for colorectal cancer in Ventura, California

Image of NRG Oncology - Pittsburgh Center in Pittsburgh, United States.

mFOLFIRINOX

Recruiting1 awardPhase 2 & 3
This trial tests if a blood test for cancer DNA can help decide if colon cancer patients need more treatment after surgery. The test looks for cancer DNA in the blood to predict if the cancer might come back and to guide further treatment.
Image of Kaiser Permanente Orange County Anaheim/Irvine Medical Center Oncology Clinics in Anaheim, United States.

Embedded primary care in cancer survivorship model

Behavioural Intervention

Recruiting1 award7 criteria
This trial looks at two different ways of providing care to cancer survivors to see which is more effective.
Image of University of Alabama at Birmingham Cancer Center in Birmingham, United States.

Eflornithine +1 More

Enzyme Inhibitor

Recruiting1 awardPhase 3
This trial will test a combination of drugs to see if they are effective in reducing the chance of cancer recurrence or developing new cancers.
Image of Massachusetts General Hospital - in Boston, United States.

Irinotecan +1 More

Topoisomerase I inhibitors

Recruiting2 awardsPhase 1 & 2
This trial is testing a new cancer drug, Lurbinectedin, in combination with another cancer drug, irinotecan. The trial will have two parts: first, they will test different doses of the drugs to see what is safe; then, they will expand the trial to include more people.
Image of START Midwest in Grand Rapids, United States.

LY3962673

Monoclonal Antibodies

Recruiting1 awardPhase 1
This trial aims to test the safety and effectiveness of a drug called LY3962673 on its own and when used with other chemotherapy drugs in patients with a specific type of advanced solid tumors. The study
Image of HonorHealth Research Institute in Scottsdale, United States.

Botensilimab

Monoclonal Antibodies

Recruiting1 awardPhase 1
This trial is testing two new drugs that help the immune system fight cancer. It targets adults with advanced cancers that haven't responded to other treatments. The drugs work by blocking proteins that usually prevent the immune system from attacking cancer cells.
Image of Sarah Cannon Research Institute in Nashville, United States.

AFNT-211

CAR T-cell Therapy

Recruiting1 awardPhase 1 & 2
This trial is for adult patients with certain types of cancer that have a specific genetic mutation. The purpose of the study is to determine the safe and effective dose of a new therapy called AFNT-211
Image of START Midwest in Grand Rapids, United States.

Pembrolizumab +1 More

Monoclonal Antibodies

Recruiting1 awardPhase 1
This trial is testing a new drug called NGM831 alone or with other drugs in patients with advanced or spreading solid tumors. The goal is to see if these treatments can help stop the cancer or help the immune system fight it better. One of the drugs being tested has been widely studied and used in various cancers, showing significant improvements in survival rates and being effective in combination with other treatments.
Image of City of Hope in Duarte, United States.

NT-112

CAR T-cell Therapy

Recruiting1 awardPhase 1
This trial tests NT-112, a personalized immune cell treatment, in patients with advanced cancers that have a specific genetic mutation. The treatment boosts the patient's immune cells to target and kill cancer cells. This highly personalized cancer therapy involves giving the patient immune cells that directly attack cancer.
Image of Alabama Oncology, Bruno Cancer Center in Birmingham, United States.

mFOLFOX6 Regimen +3 More

Small Molecule

Recruiting2 awardsPhase 3
This trial is testing a new treatment for patients with colorectal cancer. The treatment combines two drugs that work together to block cancer growth and prevent its spread. One of the drugs has shown promise in treating other types of cancer as well.

Phase 3 Trials

Trials With No Placebo

Frequently Asked Questions

Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.